title: Evaluation of gemcitabine in relapsed or refractory multiple myeloma.
authors.forename: Xavier
authors.initials: X
authors.lastname: Leleu
authors.forename: Jacques
authors.initials: J
authors.lastname: Troncy
authors.forename: Fadela
authors.initials: F
authors.lastname: Bouafia
authors.forename: Mauricette
authors.initials: M
authors.lastname: Michallet
authors.forename: Thierry
authors.initials: T
authors.lastname: Facon
authors.forename: Charles
authors.initials: C
authors.lastname: Dumontet
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine